J&J And AstraZeneca Warn Of Topamax/Toprol Name Confusion
This article was originally published in The Pink Sheet Daily
Executive Summary
J&J is aware of about 100 reports of medication errors that occurred due to confusion between its anti-epileptic Topamax and AstraZeneca's beta blocker Toprol XR in the eight years both drugs have been on the market.